SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-016044
Filing Date
2012-03-07
Accepted
2012-03-07 08:00:02
Documents
4
Period of Report
2012-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-6462_18k.htm 8-K 26235
2 EX-10.1 a12-6462_1ex10d1.htm EX-10.1 65600
3 EX-99.1 a12-6462_1ex99d1.htm EX-99.1 195569
4 GRAPHIC g64621mki001.jpg GRAPHIC 3870
  Complete submission text file 0001104659-12-016044.txt   294239
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 12672478
SIC: 2835 In Vitro & In Vivo Diagnostic Substances